-
Altria’s impressive 7.2% dividend yield is supported by a history of consistent dividend increases.
-
Altria’s most significant business is selling smokable tobacco, which accounts for nearly 90% of its revenue.
-
The company’s cigarette volumes have been in decline for years.
If you don’t look under the hood, Altria (NYSE: MO) appears to be a very compelling investment. It operates in the consumer staples sector, it has a very large 7.2% yield, and the dividend has been increased regularly for years.
Before you jump on the stock, thinking you’ve set yourself up for a lifetime of reliable dividend income, lift up the covers and take a closer look at the business that backs the dividend.
Here’s why you might not like what you see.
Consumer staples companies produce products that are purchased regularly, regardless of the market or economic environment, and typically have a modest cost. Brand loyalty is often a significant factor in this space as well. All these factors work in favor of Altria’s most important offering: Smokable tobacco products, such as cigarettes. Taken as a group, smokeable tobacco accounts for a huge 88% of the company’s top line.
Most consumer staples products are necessity items, like food, toilet paper, and toothpaste. You most certainly need to buy these items regularly. Tobacco isn’t a necessity. It is a consumer staple largely because of the addictive nature of nicotine, which keeps buyers coming back for more. Unlike makers of deodorant and similar products, tobacco stocks are really sin stocks. That’s important because Altria’s smokable products group has been in decline for years as cigarette smoking has increasingly fallen out of favor with consumers.
In the third quarter of 2025, volume in the business dropped 8%. Through the first nine months of the year, volume was off by 10.3%. In 2024, volumes declined 10%. In 2023, volumes fell 9.6%. That is a terrible trend that should be a warning sign to anyone who owns or is thinking about owning tobacco-focused Altria. Most investors would be running for the hills if this were a company that produced food.
Given that backdrop, it should come as little surprise that the top line of Altria’s income statement fell 3% in Q3 2025, while it was down roughly 3.4% through the first nine months of the year. What might be confusing is that the company’s adjusted earnings rose 3.6% and 5.9%, respectively, over those same time periods.
There are two things to monitor here. First, the volume decline didn’t lead to as material a revenue decline as you might expect. That’s because the addictive nature of nicotine has allowed Altria and its peers to jack up the price of their smokes on a regular basis. For a long time, the additional revenue from price hikes more than offset the effect from volume declines, but that is now ancient history. Price hikes now appear to be a part of the volume problem.
The second issue to consider is earnings, which rose despite the drop on the top line. That was largely thanks to the company’s stock buybacks. In Q3 2025, Altria repurchased 1.9 million shares, bringing the total to 12.3 million shares over the first nine months of the year. Year over year, the company’s share count fell 1.4% in Q3 and 2.4% through the first three quarters.
To be fair, the company’s cost-cutting efforts have also helped support the bottom line. However, the big-picture story remains the same. Altria’s most significant business is under severe pressure, which is having an increasingly negative effect on the company’s financial results. Since the volume decline in smokable products is unlikely to change direction, buying Altria is, effectively, buying a business that’s in decline.
Despite a lofty yield and strong dividend history, most conservative dividend investors will probably be better off avoiding Altria. In fact, if you buy Altria, you are really betting that management can milk the dying smokable tobacco business long enough to fund the buildout of divisions capable of offsetting the ongoing declines.
That might happen, but so far, Altria’s efforts have been less than impressive, with failed efforts in vaping and marijuana that cost investors billions in write-offs. The risk-reward balance for this high-yield stock is currently tilted in the wrong direction for long-term investors.
Before you buy stock in Altria Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Altria Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $540,587!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,118,210!*
Now, it’s worth noting Stock Advisor’s total average return is 991% — a market-crushing outperformance compared to 195% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of December 1, 2025
Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Could Buying High-Yield Altria Today Set You Up for Life? was originally published by The Motley Fool
Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: finance.yahoo.com
